Results 71 to 80 of about 12,158,807 (343)

Treatment Decision‐Making Roles and Preferences Among Adolescents and Young Adults With Cancer

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Decision‐making (DM) dynamics between adolescents and young adults (AYAs) with cancer, parents, and oncologists remain underexplored in diverse populations. We examined cancer treatment DM preferences among an ethnically and socioeconomically diverse group of AYAs and their parents.
Amanda M. Gutierrez, Jill O. Robinson, Wendy A. Allen‐Rhoades, Hadley S. Smith, Isabel Canfield, Rebecca L. Hsu, Sarah R. Scollon, Lauren R. Desrosiers‐Battu, Nicole M. Schneider, Frank Y. Lin, Donald Williams Parsons, Sharon E. Plon, Mary A. Majumder, Janet Malek, Amy L. McGuire   +14 more
wiley   +1 more source

Clinical Features and Comparative Treatment Outcomes of Atomoxetine and Methylphenidate in Omani Adults with ADHD

Oman Medical Journal
Objectives: To investigate the clinical presentation and treatment outcomes in Omani adults diagnosed with attention-deficit hyperactivity disorder (ADHD), with a focus on the efficacy of atomoxetine and methylphenidate in reducing symptoms, and identify
Omayma Al Kiyumi, Tamadhir Al-Mahrouqi, Salim Al-Huseini, Sathiya Panchatcharam, Amira Al-Hosni, Samir Al-Adawi, Hassan Mirza   +6 more
doaj   +1 more source

Patient reported outcome assessment must be inclusive and equitable

Nature Medicine, 2022
M. Calvert, S. Cruz Rivera, A. Retzer, S. Hughes, L. Campbell, Barbara Molony-Oates, O. Aiyegbusi, A. Stover, Roger Wilson, Christel McMullan, N. Anderson, Grace M. Turner, E. Davies, Rav Verdi, G. Velikova, P. Kamudoni, S. Muslim, Adrian Gheorghe, D. O’Connor, Xiaoxuan Liu, Albert W. Wu, A. Denniston   +21 more
semanticscholar   +1 more source

KBG Syndrome: A Case Report and Longitudinal Assessment of Long‐Acting Recombinant Human Growth Hormone Therapy

Genetics in Medicine, 2015
Disclaimer: These ACMG Standards and Guidelines were developed primarily as an educational resource for clinical laboratory geneticists to help them provide quality clinical laboratory services.
Sue Richards, Nazneen Aziz, S. Bale, D. Bick, Soma Das, J. Gastier-Foster, W. Grody, M. Hegde, E. Lyon, E. Spector, K. Voelkerding, H. Rehm   +11 more
semanticscholar   +1 more source

Parent Quality of Life at Two Years Following Their Child's Completion of Acute Lymphoblastic Leukemia Treatment

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Parents of children treated for acute lymphoblastic leukemia (ALL) often experience significant caregiver burden and disruption to their well‐being. While parent quality of life (QoL) during treatment is well characterized, little is known about outcomes during early survivorship.
Sara Dal Pra, Maria McCarthy, Michael Takagi, Cinzia De Luca   +3 more
wiley   +1 more source

A PRSZT Registry Analysis of Prognostic Factors Influencing Survival and Relapse Rates After Second Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT A second allogeneic (allo‐)hematopoietic stem cell transplantation (HSCT2) is a potential curative option for pediatric patients with acute lymphoblastic leukemia (ALL) following relapse after first allogeneic transplantation (HSCT1), but its efficacy is limited by high relapse rates and transplant‐related toxicity in highly pretreated ...
Ava Momm, Imme Haubitz, Rita Beier, Martin Zimmermann, Andrej Lissat, Peter Bader, Matthias Eyrich, Jan‐Henning Klusmann, Matthias Wölfl, Paul‐Gerhardt Schlegel, Verena Wiegering   +10 more
wiley   +1 more source

The risks, benefits, and resource implications of different diets in gastrostomy-fed children: The YourTube mixed method study

Health Technology Assessment
Background Many children receive some or all their nutritional intake via a gastrostomy. More parents are using home-blended meals to feed their children, reporting beneficial effects, such as improved gastro-oesophageal reflux and less distress.
Lorna Fraser, Andre Bedendo, Mark O’Neill, Johanna Taylor, Julia Hackett, Karen Horridge, Janet Cade, Gerry Richardson, Thai Han Phung, Bryony Beresford, Alison McCarter, Catherine Hewitt   +11 more
doaj   +1 more source

Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials

Trials, 2014
BackgroundBlinded outcome assessment is recommended in open-label trials to reduce bias, however it is not always feasible. It is therefore important to find other means of reducing bias in these scenarios.MethodsWe describe two randomised trials where ...
B. Kahan, S. Cro, C. Doré, D. Bratton, S. Rehal, N. Maskell, N. Rahman, V. Jairath   +7 more
semanticscholar   +1 more source

Evaluation of the Utility of Baseline Echocardiogram in Patients With Standard Risk Precursor B‐Lymphoblastic Leukemia

Pediatric Blood &Cancer, EarlyView.
Abstract Background A routine baseline echocardiogram is often obtained prior to anthracycline administration in children with cancer. The utility of baseline echocardiogram is unclear in patients with standard risk B‐cell acute lymphoblastic leukemia (SR B‐ALL) as their anthracycline cumulative dose is low.
Ziyad Alrajhi, Alice Pozza, Luc Mertens, Adam Paul Yan, Sarah Alexander   +4 more
wiley   +1 more source

One-Year Weight Follow-Up Results in Patients Followed in Obesity Clinic and Evaluation of the Association Between Annual Weight Loss Rate and the Number of Visits

Ankara Medical Journal, 2020
INTRODUCTION: The aim of this study was to evaluate the annual weight loss rate and the number of visits to obesity follow-up and to provide more effective follow-up of the patients with obesity follow-up.
Fatma Olcay Coşkun, Bülent Can
doaj   +1 more source